Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1996 Jan;74(1):81–87. doi: 10.1136/adc.74.1.81

Nutritional management of cystic fibrosis.

A MacDonald 1
PMCID: PMC1511597  PMID: 8660059

Abstract

Nutritional support is an integral part of the management of cystic fibrosis patients. It is arguably best provided by a qualified dietitian and nutritional care sister working in conjunction with the rest of the cystic fibrosis team. The patient's nutritional needs should be assessed, regularly reviewed, and nutritional treatment tailored to meet the changing clinical and psychosocial needs of the patient. Nutritional intervention is not without complications, and in particular attention to normal feeding behaviour and vigilance when instituting supplementary nutrition may prevent many feeding difficulties.

Full text

PDF
81

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachrach L. K., Loutit C. W., Moss R. B. Osteopenia in adults with cystic fibrosis. Am J Med. 1994 Jan;96(1):27–34. doi: 10.1016/0002-9343(94)90112-0. [DOI] [PubMed] [Google Scholar]
  2. Beverley D. W., Kelleher J., MacDonald A., Littlewood J. M., Robinson T., Walters M. P. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child. 1987 Jun;62(6):564–568. doi: 10.1136/adc.62.6.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bines J. E., Israel E. J. Hypoproteinemia, anemia, and failure to thrive in an infant. Gastroenterology. 1991 Sep;101(3):848–856. doi: 10.1016/0016-5085(91)90549-z. [DOI] [PubMed] [Google Scholar]
  4. Boland M. P., Stoski D. S., MacDonald N. E., Soucy P., Patrick J. Chronic jejunostomy feeding with a non-elemental formula in undernourished patients with cystic fibrosis. Lancet. 1986 Feb 1;1(8475):232–234. doi: 10.1016/s0140-6736(86)90772-5. [DOI] [PubMed] [Google Scholar]
  5. Bowler I. M., Wolfe S. P., Owens H. M., Sheldon T. A., Littlewood J. M., Walters M. P. A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child. 1993 Feb;68(2):227–230. doi: 10.1136/adc.68.2.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brady M. S., Rickard K., Yu P. L., Eigen H. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. J Am Diet Assoc. 1992 Jul;92(7):813–817. [PubMed] [Google Scholar]
  7. Brooks H. L., Jr, Driebe W. T., Jr, Schemmer G. G. Xerophthalmia and cystic fibrosis. Arch Ophthalmol. 1990 Mar;108(3):354–357. doi: 10.1001/archopht.1990.01070050052029. [DOI] [PubMed] [Google Scholar]
  8. Buchdahl R. M., Cox M., Fulleylove C., Marchant J. L., Tomkins A. M., Brueton M. J., Warner J. O. Increased resting energy expenditure in cystic fibrosis. J Appl Physiol (1985) 1988 May;64(5):1810–1816. doi: 10.1152/jappl.1988.64.5.1810. [DOI] [PubMed] [Google Scholar]
  9. Buchdahl R. M., Fulleylove C., Marchant J. L., Warner J. O., Brueton M. J. Energy and nutrient intakes in cystic fibrosis. Arch Dis Child. 1989 Mar;64(3):373–378. doi: 10.1136/adc.64.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Campbell C. A., Forrest J., Musgrove C. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet. 1994 Jan 8;343(8889):109–110. [PubMed] [Google Scholar]
  11. Corey M., McLaughlin F. J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. doi: 10.1016/0895-4356(88)90063-7. [DOI] [PubMed] [Google Scholar]
  12. Dalzell A. M., Shepherd R. W., Dean B., Cleghorn G. J., Holt T. L., Francis P. J. Nutritional rehabilitation in cystic fibrosis: a 5 year follow-up study. J Pediatr Gastroenterol Nutr. 1992 Aug;15(2):141–145. doi: 10.1097/00005176-199208000-00007. [DOI] [PubMed] [Google Scholar]
  13. Dodge J. A. Nutrition in cystic fibrosis: a historical overview. Proc Nutr Soc. 1992 Aug;51(2):225–235. doi: 10.1079/pns19920033. [DOI] [PubMed] [Google Scholar]
  14. Durie P. R., Newth C. J., Forstner G. G., Gall D. G. Malabsorption of medium-chain triglycerides in infants with cystic fibrosis: correction with pancreatic enzyme supplement. J Pediatr. 1980 May;96(5):862–864. doi: 10.1016/s0022-3476(80)80559-2. [DOI] [PubMed] [Google Scholar]
  15. Durie P. R., Pencharz P. B. Cystic fibrosis: nutrition. Br Med Bull. 1992 Oct;48(4):823–846. doi: 10.1093/oxfordjournals.bmb.a072580. [DOI] [PubMed] [Google Scholar]
  16. Eid N. S., Shoemaker L. R., Samiec T. D. Vitamin A in cystic fibrosis: case report and review of the literature. J Pediatr Gastroenterol Nutr. 1990 Feb;10(2):265–269. [PubMed] [Google Scholar]
  17. Farrell P. M., Mischler E. H., Sondel S. A., Palta M. Predigested formula for infants with cystic fibrosis. J Am Diet Assoc. 1987 Oct;87(10):1353–1356. [PubMed] [Google Scholar]
  18. Greer R., Shepherd R., Cleghorn G., Bowling F. G., Holt T. Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis. J Pediatr Gastroenterol Nutr. 1991 Jul;13(1):52–58. doi: 10.1097/00005176-199107000-00010. [DOI] [PubMed] [Google Scholar]
  19. Grey A. B., Ames R. W., Matthews R. D., Reid I. R. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax. 1993 Jun;48(6):589–593. doi: 10.1136/thx.48.6.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hanning R. M., Blimkie C. J., Bar-Or O., Lands L. C., Moss L. A., Wilson W. M. Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference? Am J Clin Nutr. 1993 Apr;57(4):580–587. doi: 10.1093/ajcn/57.4.580. [DOI] [PubMed] [Google Scholar]
  21. Holliday K. E., Allen J. R., Waters D. L., Gruca M. A., Thompson S. M., Gaskin K. J. Growth of human milk-fed and formula-fed infants with cystic fibrosis. J Pediatr. 1991 Jan;118(1):77–79. doi: 10.1016/s0022-3476(05)81850-5. [DOI] [PubMed] [Google Scholar]
  22. James D. R., Owen G., Campbell I. A., Goodchild M. C. Vitamin A absorption in cystic fibrosis: risk of hypervitaminosis A. Gut. 1992 May;33(5):707–710. doi: 10.1136/gut.33.5.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kane R. E., Hobbs P. J., Black P. G. Comparison of low, medium, and high carbohydrate formulas for nighttime enteral feedings in cystic fibrosis patients. JPEN J Parenter Enteral Nutr. 1990 Jan-Feb;14(1):47–52. doi: 10.1177/014860719001400147. [DOI] [PubMed] [Google Scholar]
  24. Kane R. E., Hobbs P. Energy and respiratory metabolism in cystic fibrosis: the influence of carbohydrate content of nutritional supplements. J Pediatr Gastroenterol Nutr. 1991 Feb;12(2):217–223. doi: 10.1097/00005176-199102000-00014. [DOI] [PubMed] [Google Scholar]
  25. Lanng S., Thorsteinsson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992 Sep;151(9):684–687. doi: 10.1007/BF01957574. [DOI] [PubMed] [Google Scholar]
  26. Laughlin J. J., Brady M. S., Eigen H. Changing feeding trends as a cause of electrolyte depletion in infants with cystic fibrosis. Pediatrics. 1981 Aug;68(2):203–207. [PubMed] [Google Scholar]
  27. Lebenthal E. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better". J Pediatr Gastroenterol Nutr. 1994 May;18(4):423–425. doi: 10.1097/00005176-199405000-00002. [DOI] [PubMed] [Google Scholar]
  28. Levy L., Durie P., Pencharz P., Corey M. Prognostic factors associated with patient survival during nutritional rehabilitation in malnourished children and adolescents with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1986 Jan;5(1):97–102. doi: 10.1097/00005176-198601000-00018. [DOI] [PubMed] [Google Scholar]
  29. Lloyd-Still J. D., Powers C. Carnitine metabolites in infants with cystic fibrosis. Acta Univ Carol Med (Praha) 1990;36(1-4):78–80. [PubMed] [Google Scholar]
  30. Lloyd D. R., Rawashdeh M. O., Booth I. W., Brown G. A. The steatocrit: an improved procedure. Ann Clin Biochem. 1992 Sep;29(Pt 5):535–540. doi: 10.1177/000456329202900508. [DOI] [PubMed] [Google Scholar]
  31. Marcus M. S., Sondel S. A., Farrell P. M., Laxova A., Carey P. M., Langhough R., Mischler E. H. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr. 1991 Sep;54(3):578–585. doi: 10.1093/ajcn/54.3.578. [DOI] [PubMed] [Google Scholar]
  32. Morrison G., Morrison J. M., Redmond A. O., Byers C. A., McCracken K. J., Dodge J. A., Guilford S. A., Bowden M. W. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther. 1992 Oct;6(5):549–555. doi: 10.1111/j.1365-2036.1992.tb00569.x. [DOI] [PubMed] [Google Scholar]
  33. Murphy J. L., Wootton S. A., Bond S. A., Jackson A. A. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child. 1991 Apr;66(4):495–500. doi: 10.1136/adc.66.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nasr S. Z., O'Leary M. H., Hillermeier C. Correction of vitamin E deficiency with fat-soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis. J Pediatr. 1993 May;122(5 Pt 1):810–812. doi: 10.1016/s0022-3476(06)80034-x. [DOI] [PubMed] [Google Scholar]
  35. O'Rawe A., Dodge J. A., Redmond A. O., McIntosh J., Brock D. J. Gene/energy interaction in cystic fibrosis. Lancet. 1990 Mar 3;335(8688):552–553. doi: 10.1016/0140-6736(90)90795-7. [DOI] [PubMed] [Google Scholar]
  36. Oades P. J., Bush A., Ong P. S., Brereton R. J. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet. 1994 Jan 8;343(8889):109–109. [PubMed] [Google Scholar]
  37. Peters S. A., Rolles C. J. Vitamin therapy in cystic fibrosis--a review and rationale. J Clin Pharm Ther. 1993 Feb;18(1):33–38. doi: 10.1111/j.1365-2710.1993.tb00563.x. [DOI] [PubMed] [Google Scholar]
  38. Pfeifer T. Diabetes in cystic fibrosis. Clin Pediatr (Phila) 1992 Nov;31(11):682–687. doi: 10.1177/000992289203101108. [DOI] [PubMed] [Google Scholar]
  39. Phillips R. J., Crock C. M., Dillon M. J., Clayton P. T., Curran A., Harper J. I. Cystic fibrosis presenting as kwashiorkor with florid skin rash. Arch Dis Child. 1993 Oct;69(4):446–448. doi: 10.1136/adc.69.4.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Portal B., Richard M. J., Ducros V., Aguilaniu B., Brunel F., Faure H., Gout J. P., Bost M., Favier A. Effect of double-blind crossover selenium supplementation on biological indices of selenium status in cystic fibrosis patients. Clin Chem. 1993 Jun;39(6):1023–1028. [PubMed] [Google Scholar]
  41. Rayner R. J., Tyrrell J. C., Hiller E. J., Marenah C., Neugebauer M. A., Vernon S. A., Brimlow G. Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis. Arch Dis Child. 1989 Aug;64(8):1151–1156. doi: 10.1136/adc.64.8.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Scott R. B., O'Loughlin E. V., Gall D. G. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr. 1985 Feb;106(2):223–227. doi: 10.1016/s0022-3476(85)80291-2. [DOI] [PubMed] [Google Scholar]
  43. Shah A., Dinwiddie R., Madge S., Prescott P., Hudson G. High dose Nutrizym 22 in cystic fibrosis. Eur J Pediatr. 1993 Sep;152(9):763–764. doi: 10.1007/BF01953997. [DOI] [PubMed] [Google Scholar]
  44. Shepherd R. W., Holt T. L., Thomas B. J., Kay L., Isles A., Francis P. J., Ward L. C. Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease. J Pediatr. 1986 Nov;109(5):788–794. doi: 10.1016/s0022-3476(86)80695-3. [DOI] [PubMed] [Google Scholar]
  45. Singer L. T., Nofer J. A., Benson-Szekely L. J., Brooks L. J. Behavioral assessment and management of food refusal in children with cystic fibrosis. J Dev Behav Pediatr. 1991 Apr;12(2):115–120. [PMC free article] [PubMed] [Google Scholar]
  46. Slesinski M. J., Gloninger M. F., Costantino J. P., Orenstein D. M. Lipid levels in adults with cystic fibrosis. J Am Diet Assoc. 1994 Apr;94(4):402–408. doi: 10.1016/0002-8223(94)90095-7. [DOI] [PubMed] [Google Scholar]
  47. Smyth R. L., van Velzen D., Smyth A. R., Lloyd D. A., Heaf D. P. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994 Jan 8;343(8889):85–86. doi: 10.1016/s0140-6736(94)90817-6. [DOI] [PubMed] [Google Scholar]
  48. Sokol R. J., Reardon M. C., Accurso F. J., Stall C., Narkewicz M., Abman S. H., Hammond K. B. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr. 1989 Nov;50(5):1064–1071. doi: 10.1093/ajcn/50.5.1064. [DOI] [PubMed] [Google Scholar]
  49. Soutter V. L., Kristidis P., Gruca M. A., Gaskin K. J. Chronic undernutrition/growth retardation in cystic fibrosis. Clin Gastroenterol. 1986 Jan;15(1):137–155. [PubMed] [Google Scholar]
  50. Spicher V., Roulet M., Schutz Y. Assessment of total energy expenditure in free-living patients with cystic fibrosis. J Pediatr. 1991 Jun;118(6):865–872. doi: 10.1016/s0022-3476(05)82196-1. [DOI] [PubMed] [Google Scholar]
  51. Stark L. J., Bowen A. M., Tyc V. L., Evans S., Passero M. A. A behavioral approach to increasing calorie consumption in children with cystic fibrosis. J Pediatr Psychol. 1990 Jun;15(3):309–326. doi: 10.1093/jpepsy/15.3.309. [DOI] [PubMed] [Google Scholar]
  52. Stark L. J., Jelalian E., Mulvihill M. M., Powers S. W., Bowen A. M., Spieth L. E., Keating K., Evans S., Creveling S., Harwood I. Eating in preschool children with cystic fibrosis and healthy peers: behavioral analysis. Pediatrics. 1995 Feb;95(2):210–215. [PubMed] [Google Scholar]
  53. Stark L. J., Knapp L. G., Bowen A. M., Powers S. W., Jelalian E., Evans S., Passero M. A., Mulvihill M. M., Hovell M. Increasing calorie consumption in children with cystic fibrosis: replication with 2-year follow-up. J Appl Behav Anal. 1993 Winter;26(4):435–450. doi: 10.1901/jaba.1993.26-435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Stead R. J., Skypala I., Hodson M. E., Batten J. C. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Thorax. 1987 Jul;42(7):533–537. doi: 10.1136/thx.42.7.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Steinkamp G., von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr. 1994 Feb;124(2):244–249. doi: 10.1016/s0022-3476(94)70312-4. [DOI] [PubMed] [Google Scholar]
  56. Vaisman N., Pencharz P. B., Corey M., Canny G. J., Hahn E. Energy expenditure of patients with cystic fibrosis. J Pediatr. 1987 Oct;111(4):496–500. doi: 10.1016/s0022-3476(87)80107-5. [DOI] [PubMed] [Google Scholar]
  57. Vyas H., Matthew D. J., Milla P. J. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study. Eur J Pediatr. 1990 Jan;149(4):241–243. doi: 10.1007/BF02106281. [DOI] [PubMed] [Google Scholar]
  58. Williams J., MacDonald A., Weller P. H., Fields J., Pandov H. Two enteric coated microspheres in cystic fibrosis. Arch Dis Child. 1990 Jun;65(6):594–597. doi: 10.1136/adc.65.6.594. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES